ScripsAmerica, Inc. engages in the distribution of generic and over-the-counter (OTC) drugs to hospitals, nursing homes, government agencies, and retail. The company is headquartered in Clifton, New Jersey. The company went IPO on 2012-05-30. The firm's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). The company also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.
Follow-Up Questions
¿Cuál es el ratio P/E de ScripsAmerica Inc (SCRCQ)?
El ratio P/E de ScripsAmerica Inc es 0
¿Quién es el CEO de ScripsAmerica Inc?
Mr. Brian Ettinger es el Chairman of the Board de ScripsAmerica Inc, se unió a la empresa desde 2011.
¿Qué tal es el rendimiento del precio de la acción SCRCQ?
El precio actual de SCRCQ es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de ScripsAmerica Inc?
ScripsAmerica Inc pertenece a la industria Retail y el sector es Consumer Staples
¿Cuál es la capitalización bursátil de ScripsAmerica Inc?
La capitalización bursátil actual de ScripsAmerica Inc es $0